Skip to main content
TDR: For Research on Diseases of Poverty

Access

  • Home Alt+0
  • Navigation Alt+1
  • Content Alt+2

Navigation

  • Home
  • About us
  • Research
  • Capacity building
  • Grants
  • Publications
    & resources
  • Partnerships
    & networks
  • Diseases
    & topics
  • News
    & events

Research on neglected priority needs, including product R&D, evaluation in real life settings, and increasing access to new tools

Developing research leadership through education, training, networks and quality management

Assessing global research needs and priorities, providing knowledge management and support for partner coordination

All the calls for research and training grants, career development fellowships and how to apply

Read, download or order TDR's publications and multimedia resources

For the latest news, press releases and TDR events

For more on TDR's strategy, governance, history and to find our staff

For more on TDR partnerships and networks

Search

Advanced search

Subnavigation

  • News and events
  • Latest news
  • TDR events
  • External events

Cholera diagnostic test evaluations needed

TDR news item
17 October 2012

Five commercially available rapid diagnostic tests (RDTs) for cholera show promise for use in field conditions, but need further study. This is the recommendation from a newly published review that took the first step in assessing developments in commercialised diagnostic tools. The authors recommend an independent assessment of these products, including technical improvements and production to trigger early detection of cholera epidemics. They also say that stringent standardization is needed to evaluate these and more tests.

Field and laboratory studies were performed in a wide range of settings demonstrating variability in performance. Only a few of the studies were sufficiently stringent, highlighting five RDTs that showed promise in field conditions; COAT, IP cholera dipstick, SMART, IP dipstick and Medicos.

Diagnosing cholera early at the onset of an epidemic, at the field level, should allow for a more timely response and a quick containment of the spread. Currently the gold standard to identify the bacteria, Vibrio cholerae, from patient samples relies on lengthy bacterial cultures, an array of biochemical tests, highly-skilled operators and numerous laboratory resources, few of which are available in remote locations. Research to develop more appropriate tools has largely focused on rapid diagnostic tests and attempts to simplify existing technologies, but no tests have undergone appropriate scrutiny to provide the evidence to make fully informed decisions on the efficacy of the tests.

The study authors, which include two TDR staff, took the first step by assessing developments in commercialised diagnostic tools, reviewing 14 previous evaluations of the 24 tests developed for the detection of Vibrio cholerae in human faecal samples since 1990. Rapid chromatographic-immuno assays (CIA) feature strongly. Polymerase chain reaction (PCR) assays maintain the ability to detect the lowest amount of bacteria; however CIAs achieve both low detection thresholds and high sensitivity and specificity, making them possible candidates for use in field conditions.

For more information, please contact:

Francis Moussy
E-mail: moussyf@who.int

Share
Email Twitter Facebook Google Delicious LinkedIn
More...
Print

Related links

  • Review of Two Decades of Cholera Diagnostics – How Far Have We Really Come?
  • More on TDR diagnostics research
  • More on cholera

You are here:

  • TDR
  • News and events
  • 2012 News and press releases
  • © WHO 2013
  • More about our sponsors
  • Contact us

Special Programme for Research and Training in Tropical Diseases (TDR)